The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - OncoMed
Leadership - OncoMed
Stock and Other Ownership Interests - OncoMed
Patents, Royalties, Other Intellectual Property - OncoMed (Inst)
Paracrine wnt-β-catenin signaling inhibition as a strategy to enhance the efficacy of anti-PD-1 antibody (Ab) therapy in a transgenic model of melanoma.
 
Christine Xiao
No Relationships to Disclose
 
Fei Zhao
No Relationships to Disclose
 
Kathy S. Evans
No Relationships to Disclose
 
Bala Theivanthiran
No Relationships to Disclose
 
John Lewicki
No Relationships to Disclose
 
Tim Hoey
Employment - OncoMed
Leadership - OncoMed
Stock and Other Ownership Interests - OncoMed
Patents, Royalties, Other Intellectual Property - OncoMed (Inst)
 
Herbert Hurwitz
Honoraria - Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Acceleron Pharma; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Incyte; Lilly; Novartis; OncoMed; TRACON Pharma
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); NCI (Inst); Novartis (Inst); Regeneron (Inst); TRACON Pharma (Inst)
 
John H. Strickler
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Celgene; Genentech/Roche; Onyx
Research Funding - Abbvie (Inst); Bayer (Inst); Exelixis (Inst); Gilead Sciences (Inst); MedImmune (Inst); OncoMed (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst)
 
Brent Allen Hanks
Stock and Other Ownership Interests - Bellicum Pharmaceuticals
Honoraria - Novartis
Consulting or Advisory Role - EMD Serono
Research Funding - Celldex; Incyte; medpacto; Merck; OncoMed